Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited is a pharmaceuticals organization. The Company's business portions incorporate US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API).

Its Rest of World portion incorporates Western Europe, Canada, Australia, New Zealand and different markets. The Company offers its items to treatment regions, for example, cardiology, neuro-psychiatry, gastroenterology, hostile to infective, diabetology and dermatology. The Company's items incorporate AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its assembling units are arranged in India, the United States and Brazil, among others. Its units deliver generics, marked generics, claim to fame items, over-the-counter (OTC) items, hostile to retroviral (ARVs) and APIs. They likewise deliver intermediates in a scope of dose shapes, including tablets, containers, injectables, salves, creams and fluids.